Imago BioSciences: Funding, Investors & Team (Oct 2026)
Imago BioSciences is a San Francisco-based clinical development company dedicated to translating state-of-the art science into novel medicines for treating diseases that currently pose great challenges to patients, their families and their physicians. The company leverages the skills and extensive experience of its team and the financial commitment of its investors to focus on a small family of orphan diseases. Imago BioSciences translates unique insights into high impact transformative therapies that alter the natural history of disease allowing patients to live longer, disease-free lives.
Imago BioSciences has raised $80.0M across 1 funding round on record, the most recent an undisclosed round of $80.0M announced in Nov 2020.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Imago BioSciences Company Profile and Key Stats
Latest funding round on record: Nov 2020.
Imago BioSciences Funding Rounds
Imago BioSciences Founders and Leadership Team
No contact details are on record for this team yet.
Imago BioSciences Funding Compared to Other Biotechnology Startups
Imago BioSciences' latest round of $80.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Imago BioSciences in Biotechnology and San Carlos
Companies Similar to Imago BioSciences
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Imago BioSciences Funding FAQs
What does Imago BioSciences do?
Imago BioSciences is a San Francisco-based clinical development company dedicated to translating state-of-the art science into novel medicines for treating diseases that currently pose great challenges to patients, their families and their physicians. The company leverages the skills and extensive experience of its team and the financial commitment of its investors to focus on a small family of orphan diseases. Imago BioSciences translates unique insights into high impact transformative therapies that alter the natural history of disease allowing patients to live longer, disease-free lives.
How much funding has Imago BioSciences raised?
Imago BioSciences has raised $80.0M across 1 round on record. The most recent is an undisclosed round of $80.0M announced in Nov 2020.
When did Imago BioSciences last raise funding?
Imago BioSciences' most recent funding round on record is an undisclosed round of $80.0M, announced in Nov 2020.
Who is the CEO of Imago BioSciences?
Hugh Rienhoff is listed as CEO at Imago BioSciences.
Where is Imago BioSciences headquartered?
Imago BioSciences is based in San Carlos, California, United States.
How many employees does Imago BioSciences have?
Imago BioSciences is in the 51-100 employee band.
How does Imago BioSciences' funding compare to other Biotechnology startups?
Imago BioSciences' latest round of $80.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Imago BioSciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Imago BioSciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.